Trudell Medical International's High-altitude Sleep Mask Now Available in Parts of Europe

LONDON, Ontario, September 14, 2018 /PRNewswire/ --

Trudell Medical International (TMI) is excited to announce its new High-Altitude Sleep Mask is now approved for sale in Austria, Belgium, France, Germany, Italy, the Netherlands, Spain, Switzerland, and the United Kingdom.  

Venturing to high-altitude locations is increasingly common, and more and more people are being exposed to the effects of these hypoxic environments. TMI's High-Altitude Sleep Mask is a new Class I medical device that provides a combination of mild exhalation resistance and CO₂ rebreathing.  The result is a drug-free method of mitigating the effects of disrupted sleep at high-altitude by reducing high-altitude periodic breathing. (1) An added benefit of the TMI High-Altitude Sleep Mask is that rebreathing improves the heat and humidity of inhaled air in the typical cold, dry environment at altitude.

Equally exciting is that a recent pilot study shows that TMI's High-Altitude Sleep Mask also reduces the severity of high-altitude headaches, the most common symptom of Acute Mountain Sickness (aka altitude sickness).(1)

For more information please visit http://www.altimatemask.com

(1)Based on unpublished results from a pilot study completed in March 2018

Jason Collins, Director Commercial Development, Trudell Medical International, JCollins@trudellmed.com, +1-519-455-7060 ext 2202

PR Newswire

Dit persbericht is via ANP Pers Support naar internationale (vak en online) media gestuurd. Heb je nieuws voor buitenlandse journalisten? Bekijk dan onze mogelijkheden of neem contact met ons op.

Verstuur nu éénmalig een persbericht

Verstuur persberichten en beeldmateriaal naar redacties in binnen- en buitenland. Via het ANP-net, het internationale medianetwerk van PR Newswire of met een perslijst op maat.

Direct persbericht versturen
070 - 41 41 234